Arcus Biosciences, Inc.
RCUS- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001724521
In the last 90 days, Arcus Biosciences, Inc. insiders filed 0 open-market purchases and 2 sales; 231 institutions reported holding it in 13F filings for Q2 2026, worth $3.78B in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Arcus Biosciences, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 193 | 2 | 187 | −4 |
| Shares | 51.9M | 11.4M | 53.3M | +12.8M (+31.5%) |
| Value | $790.9M | $173.2M | $815.7M | +$198.0M (+32.1%) |
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (22)
Institutions that held Arcus Biosciences, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 9,732,399 | $148.8M | 0.00% |
| Siren, L.L.C. | 1,612,077 | $24.6M | 1.23% |
| Walleye Capital LLC | 238,544 | $3.65M | 0.04% |
| Balyasny Asset Management LLC | 48,580 | $742.8K | 0.00% |
| Tudor Investment Corp Et Al | 45,650 | $698.0K | 0.01% |
| Man Group plc | 35,940 | $549.5K | 0.00% |
| Martingale Asset Management L P | 16,426 | $251.2K | 0.01% |
| Intech Investment Management LLC | 15,959 | $244.0K | 0.00% |
| PEAK6 Investments LLC | 15,000 | $229.3K | 0.01% |
| Dark Forest Capital Management LP | 14,894 | $227.7K | 0.03% |
| ProShare Advisors LLC | 11,341 | $173.4K | 0.00% |
| Federated Hermes, Inc. | 3,178 | $48.6K | 0.00% |
| Point72 Hong Kong Ltd | 3,100 | $47.4K | 0.00% |
| Acadian Asset Management LLC | 1,296 | $19.0K | 0.00% |
| Bessemer Group Inc | 70 | $1.00K | 0.00% |
| Sterling Capital Management LLC | 56 | $856 | 0.00% |
| Signaturefd, LLC | 40 | $612 | 0.00% |
| Capital Performance Advisors LLP | 10 | $153 | 0.00% |
| EverSource Wealth Advisors, LLC | 8 | $122 | 0.00% |
| Mendota Financial Group, LLC | 7 | $108 | 0.00% |
| Farther Finance Advisors, LLC | 1 | $15 | 0.00% |
| Hemington Wealth Management | 1 | $0 | 0.00% |
Sold out (26)
Institutions that held Arcus Biosciences, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
Not filed for Q3 2024 yet (2)
Institutions that held Arcus Biosciences, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 9,763,113 | $148.7M |
| Invus Financial Advisors, LLC | 1,612,077 | $24.6M |